Skip to content

Clinical trials

Completed Phase 2/3 Mental Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 2/3 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20091
20101
20125
20141
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation5
Arizona State University1
Bo Hu1
Duke University1
Edgard Costa de Vilhena1
Icahn School of Medicine at Mount Sinai1
Joint Child Health Project, Mauritius1
Lady Davis Institute1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
University of Southern California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders15
Schizophrenia5
Alzheimer Disease1
Antisocial Personality Disorder1
Brain Diseases1
Cognitive Dysfunction1
Dementia1
Depressive Disorder1
Depressive Disorder, Treatment-Resistant1
Dystonia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.